The Food and Drug Administration (FDA) is requesting approval of a new generic for collecting information through the use of quantitative methods for studies about tobacco products. FDA will need to employ quantitative research, including surveys and experimental studies to assess knowledge and perceptions about tobacco-related topics with specific target audiences. FDA will only submit an individual generic collection for approval under this generic clearance if the individual collection meets the outlined conditions.
The latest form for Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications expires 2021-10-31 and can be found here.
Document Name |
---|
Supplementary Document |
Justification for No Material/Nonsubstantive Change |
Justification for No Material/Nonsubstantive Change |
Justification for No Material/Nonsubstantive Change |
Supporting Statement A |
Supporting Statement B |
Supplementary Document |
Supplementary Document |
Federal Enterprise Architecture: Health - Consumer Health and Safety